GH Research (GHRS) Cash & Current Investments (2020 - 2025)

GH Research (GHRS) recorded quarterly Cash & Current Investments of $100.8 million in Q4 2025, little changed quarter-over-quarter from $100.8 million in Q3 2025, and down 16.13% on a YoY basis from $120.2 million in Q4 2024.

GH Research (GHRS) Cash & Current Investments (2020 - 2025) Analysis & Trends

GH Research's Cash & Current Investments history runs 6 years deep, the most recent figure standing at $100.8 million for Q4 2025.

  • In Q4 2025, Cash & Current Investments fell 16.13% year-over-year to $100.8 million; the TTM figure through Dec 2025 stood at $100.8 million (down 16.13% YoY), while the FY2025 annual figure was $100.8 million, down 16.13% from the prior year.
  • Cash & Current Investments was $100.8 million for Q4 2025 at GH Research, roughly flat from $100.8 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $280.7 million in Q3 2021 to a low of $5.9 million in Q1 2021.
  • Historically, Cash & Current Investments has averaged $163.3 million across 5 years, with a median of $131.6 million in 2023.
  • The sharpest annual moves came in 2021 and 2024: Cash & Current Investments surged 5535620.0% in 2021, then slumped 44.65% in 2024.
  • A 5-year view of Cash & Current Investments shows it stood at $276.8 million in 2021, then plunged by 40.04% to $166.0 million in 2022, then slipped by 19.23% to $134.0 million in 2023, then dropped by 10.34% to $120.2 million in 2024, then decreased by 16.13% to $100.8 million in 2025.
  • The last three Cash & Current Investments figures came in at $100.8 million (Q4 2025), $100.8 million (Q3 2025), and $100.8 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - 32.30 Mn
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - 2.13 Mn
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 286.70 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - 2.77 Mn
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - 18.44 Mn
7 Psyence Biomedical 241.78 Bn 241.78 Bn - 7.20 Mn
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 7.25 Bn
9 Abivax 94.26 Bn 94.26 Bn - -
10 GH Research 9.73 Bn 9.63 Bn - 100.79 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 100.79 Mn
Sep 30, 2025 100.79 Mn
Jun 30, 2025 100.79 Mn
Mar 31, 2025 113.35 Mn
Dec 31, 2024 120.18 Mn
Sep 30, 2024 122.58 Mn
Jun 30, 2024 129.10 Mn
Mar 31, 2024 128.83 Mn
Dec 31, 2023 134.04 Mn
Sep 30, 2023 221.45 Mn
Jun 30, 2023 220.68 Mn
Mar 31, 2023 220.01 Mn
Dec 31, 2022 165.96 Mn
Sep 30, 2022 276.78 Mn
Jun 30, 2022 265.38 Mn
Mar 31, 2022 276.78 Mn
Dec 31, 2021 276.79 Mn
Sep 30, 2021 280.75 Mn
Jun 30, 2021 5.90 Mn
Mar 31, 2021 5.90 Mn